Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Abbott Laboratories

Market Cap 154B 133B 122B 114B 214B 14,599B 218B 1,443B 563B 7,106B 576B 564B 24,604B P/E Ratio 2026 *
22.2x
P/E Ratio 2027 * 19x
Enterprise Value 165B 143B 132B 123B 231B 15,714B 234B 1,554B 606B 7,648B 620B 607B 26,483B EV / Sales 2026 *
3.29x
EV / Sales 2027 * 2.97x
Free-Float
86.73%
Yield 2026 *
2.89%
Yield 2027 * 3.08%
1 day+0.03%
1 week-3.17%
Current month+3.01%
1 month+4.54%
3 months-18.46%
6 months-29.71%
Current year-29.62%
1 week 87.07
Extreme 87.0706
92.02
1 month 84.05
Extreme 84.05
92.73
Current year 81.97
Extreme 81.97
129.46
1 year 81.97
Extreme 81.97
139.06
3 years 81.97
Extreme 81.97
141.23
5 years 81.97
Extreme 81.97
142.6
10 years 36.76
Extreme 36.76
142.6
Manager TitleAgeSince
Chief Executive Officer 52 30/03/2020
Director of Finance/CFO 53 31/08/2023
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 08/12/2011
Director/Board Member 67 08/12/2011
Director/Board Member 71 15/02/2017
Date Insider Type Main position Quantity % Market Cap.
04-27Other

Head of Human Resources

5,314 0.0003%
04-23Free

Director

2,286 0.0001%
04-23Other

Director

131,451 0.0076%
Change 5-day change 1-year change 3-year change Capi.($)
-1.64%-3.17%-35.38%-13.04% 154B
-0.16%-1.80%-9.37%-4.84% 103B
+0.07%+2.41%-4.53%+57.08% 54.8B
+3.00%+0.30%+55.27%+51.53% 55.22B
-0.75%-3.25%-16.18%-41.67% 40.3B
-1.40%+8.93% - - 30.96B
+0.16%+3.44%-9.03%-40.61% 29.08B
-0.46%+4.55%+46.20%-7.99% 23.23B
-2.85%-3.53%-16.97%-1.50% 20.25B
+0.16%-2.26%-14.38%-0.16% 20.23B
Average -0.22%+0.69%-0.48%-0.13% 53.06B
Weighted average by Cap. +0.04%-0.39%-8.14%+0.79%

Financials

2026 *2027 *
Net sales 50.29B 43.44B 40.03B 37.47B 70.21B 4,780B 71.3B 473B 184B 2,327B 189B 185B 8,056B 54.79B 47.32B 43.61B 40.82B 76.5B 5,208B 77.69B 515B 201B 2,535B 206B 201B 8,777B
Net income 7.02B 6.06B 5.59B 5.23B 9.8B 667B 9.95B 65.96B 25.72B 325B 26.34B 25.78B 1,124B 8.39B 7.25B 6.68B 6.25B 11.72B 798B 11.9B 78.87B 30.75B 388B 31.5B 30.83B 1,344B
Net Debt 11.73B 10.13B 9.33B 8.74B 16.37B 1,115B 16.63B 110B 42.97B 543B 44.01B 43.07B 1,878B 8.88B 7.67B 7.07B 6.62B 12.4B 844B 12.59B 83.48B 32.55B 411B 33.34B 32.63B 1,423B
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
115,000
Date Price Change Volume
12/06/26 88.18 $ -1.64% 13,759,091
11/06/26 89.65 $ +0.54% 15,088,866
10/06/26 89.17 $ -2.28% 11,853,108
09/06/26 91.25 $ +0.83% 14,109,595
08/06/26 90.50 $ -0.63% 13,308,687
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
88.18USD
Average target price
116.54USD
Spread / Average Target
+32.16%

Quarterly revenue - Rate of surprise

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!